Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Suggestions that the FDA is the main obstacle to creating new drugs are widespread and have the effect of diverting attention from more significant problems facing the biotech industry. These include counterproductive management and organizational trends, as well as a crisis in biomedical research.
